Cancer Genetics CEO John Roberts' 2021 pay jumps 470% to $1.6M
Cancer Genetics reports 2021 executive compensation
By ExecPay News
Published: June 14, 2022
Cancer Genetics reported fiscal year 2021 executive compensation information on June 14, 2022.
In 2021, four executives at Cancer Genetics received on average a compensation package of $994K, a 178% increase compared to previous year.
Average pay of disclosed executives at Cancer Genetics
John A. Roberts, Chief Executive Officer, received $1.6M in total, which increased by 470% compared to 2020. 62% of Roberts' compensation, or $994K, was in option awards. Roberts also received $175K in bonus and $423K in salary.
Yung-Ping Yeh, Chief Information Officer, received a compensation package of $869K. 69% of the compensation package, or $596K, was in option awards.
Ralf Brandt, President, Discovery & Early Development Services, earned $843K in 2021, a 93% increase compared to previous year.
Andrew D. C. LaFrence, Chief Financial Officer, received $674K in 2021.
Related executives
You may also like
Source: SEC filing on June 14, 2022.